Complement activation in the brain after experimental intracerebral hemorrhage

Journal of Neurosurgery

Volumn 92, Issue 6, 2000, Pages 1016-1022

  Hua, Ya ^a   Xi, Guohua ^a   Keep, Richard F ^a   Hoff, Julian T ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cerebral hemorrhage; Clusterin; Complement factor C3d; Membrane attack complex; N acetylheparin; Rat

Indexed keywords

CLUSTERIN; COMPLEMENT; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C9; COMPLEMENT MEMBRANE ATTACK COMPLEX; HEMOGLOBIN; HEPARIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN EDEMA; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN WATER; COMPLEMENT ACTIVATION; CONTROLLED STUDY; HEMOLYSIS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034128227     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2000.92.6.1016     Document Type: Article

References (32)

1. Bellander BM, von Holst H, Fredman P, et al: Activation of the complement cascade and increase of clusterin in the brain following a cortical contusion in the adult rat. J Neurosurg 85: 468-475, 1996
2. Bhakdi S, Tranum-Jensen J: On the cause and nature of C9-related heterogeneity of terminal complement complexes generated on target erythrocytes through the action of whole serum. J Immunol 133:1453-1463, 1984
3. Black SC, Gralinski MR, Friedrichs GS, et al: Cardioprotective effects of heparin of N-acetylheparin in an in vivo model of myocardial ischaemic and reperfusion injury. Cardiovasc Res 29:629-636, 1995
4. Boggs LN, Fuson KS, Baez M, et al: Clusterin (Apo J) protects against in vitro amyloid-β (1-40) neurotoxicity. J Neurochem 67:1324-1327, 1996
5. Dailey AT, Avellino AM, Benthem L, et al: Complement depletion reduces macrophage infiltration and activation during Wallerian degeneration and axonal regeneration. J Neurosci 18: 6713-6722, 1998
6. Del Bigio MR, Yan HJ, Buist R, et al: Experimental intracerebral hemorrhage in rats. Magnetic resonance imaging and histopathological correlates. Stroke 27:2312-2320, 1996
7. Ecker EE, Gross P: Anticomplementary power of heparin. J Infect Dis 44:250-253, 1929
8. Edens RE, Lindhardt RJ, Bell CS, et al: Heparin and derivatized heparin inhibit zymosan and cobra venom factor activation of complement in serum. Immunopharmacology 27:145-153, 1994
9. Friedrichs GS, Kilgore KS, Manley PJ, et al: Effects of heparin and N-acetyl heparin on ischemia/reperfusion-induced alterations in myocardial function in the rabbit isolated heart. Circ Res 75:701-710, 1994
10. German JW, Gross CE, Giclas P, et al: Systemic complement depletion inhibits experimental cerebral vasospasm. Neurosurgery 39:141-146, 1996
11. Giannakopoulos P, Kovari E, French LE, et al: Possible neuroprotective role of clusterin in Alzheimer's disease: a quantitative immunocytochemical study. Acta Neuropathol 95: 387-394, 1998
12. Hansch GM, Shin MI: Complement attack phase, in Rother K, Till GO, Hansch GM (eds): The Complement System. Heidelberg: Springer-Verlag, 1998, pp 115-145
13. α-glycosalted complement inhibitory protein. Science 285:595-599, 1999
14. Kirschfink M: Controlling the complement system in inflammation. Immunopharmacology 38:51-62, 1997
15. Lee KR, Betz AL, Keep RF, et al: Intracerebral infusion of thrombin as a cause of brain edema. J Neurosurg 83: 1045-1050, 1995
16. Lee KR. Colon GP, Betz AL, et al: Edema from intracerebral hemorrhage: the role of thrombin. J Neurosurg 84:91-96, 1996
17. Lindsberg PJ, Öhman J, Lento T, et al: Complement activation in the central nervous system following blood-brain barrier damage in man. Ann Neurol 40:587-596, 1996
18. Lucchesi BR: Complement activation, neutrophils, and oxygen radicals in reperfusion injury. Stroke 24 (Suppl 12): 141-147, 1993
19. McGeer PL, Akiyama H, Itagaki S, et al: Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci Lett 107:341-346, 1989
20. Østergaard JR, Kristensen BØ, Svehag SE, et al: Immune complexes and complement activation following rupture of intracranial saccular aneurysms. J Neurosurg 66:891-897, 1987
21. Park CC, Shin ML, Simard JM: The complement membrane attack complex and the bystander effect in cerebral vasospasm. J Neurosurg 87:294-300, 1997
22. Park JL, Kilgore KS, Naylor KB, et al: N-Acetylheparin pretreatment reduces infarct size in the rabbit. Pharmacology 58: 120-131, 1999
23. Pasinetti GM, Johnson SA, Oda T, et al: Clusterin (SGP-2): a multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain. J Comp Neurol 339: 387-400, 1994
24. Patel TR, Schielke GP, Hoff JT, et al: Comparison of cerebral blood flow and injury following intracerebral and subdural hematoma in the rat. Brain Res 829:125-133, 1999
25. Qureshi AI, Wilson DA, Hanley DF, et al: No evidence for an ischemic penumbra in massive experimental intracerebral hemorrhage. Neurology 52:266-272, 1999
26. Vasthare US, Barone FC, Sarau HM, et al: Complement depletion improves neurological function in cerebral ischemia. Brain Res Bull 45:413-419, 1998
27. Vriesendorp FJ, Flynn RE, Malone MR, et al: Systemic complement depletion reduces inflammation and demyelination in adoptive transfer experimental allergic neuritis. Acta Neuropathol 95:297-301, 1998
28. Weiler JM, Edens RE, Linhardt RJ, et al: Heparin and modified heparin inhibit complement activation in vivo. J Immunol 148: 3210-3215, 1992
29. Xi G, Keep RF, Hoff JT: Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats. J Neurosurg 89:991-996, 1998
30. Xi G, Keep RF, Hua Y, et al: Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning. Stroke 30: 1247-1255, 1999
31. Xi G, Wagner KR, Keep RF, et al: The role of blood clot formation on early edema development following experimental intracerebral hemorrhage. Stroke 29:2580-2586, 1998
32. Yam P, Petz LD, Tourtellotte WW, et al: Measurement of complement components in cerebrospinal fluid by radioimmunoassay in patients with multiple sclerosis. Clin Immunol Immunopathol 17:492-505, 1980